Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02923141 · ClinicalTrials.gov registry record · NA

Trauma Intervention for Affect Regulation, AIDS, and Substances

A NA study of Post Traumatic Stress Disorder and Human Immunodeficiency Virus, sponsored by University of Miami.

Completed
Registry status
NA
Development phase
16
Enrollment target
1
Study location

NCT02923141: Completed NA study of Post Traumatic Stress Disorder and Human Immunodeficiency Virus, sponsored by University of Miami.

NCT02923141 is a NA study of Post Traumatic Stress Disorder and Human Immunodeficiency Virus that has completed, run by University of Miami. The registered enrollment target is 16 participants, below the 664-participant average among 262 other Post Traumatic Stress Disorder trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02923141, a NA study of Post Traumatic Stress Disorder and Human Immunodeficiency Virus, has completed, sponsored by University of Miami.

COMPLETED
Registry status
NA
Development phase
16 participants
Enrollment target
1
Study location

Study Summary

The Purpose of this study is to see if it is possible to deliver an intervention that targets trauma, substance use, and engagement in HIV care with HIV-positive women.

Interventions

  • BEHAVIORAL Contingency Management
  • BEHAVIORAL Neutral Writing
  • BEHAVIORAL Expressive Writing

Study Locations (1)

Florida

  • Clinical Research Building - Miami

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2017-01
Est. Completion 2018-07
Phase NA
University of Miami

721 total trials

What the finished NCT02923141 record still lists

NCT02923141 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 664-participant average among 262 other Post Traumatic Stress Disorder trials with a reported enrollment target (98% lower).

The record links to 3 conditions, with Post Traumatic Stress Disorder appearing as the primary indexed condition, and to 3 interventions - of which Contingency Management is the first listed.

NCT02923141 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT02923141 about?

NCT02923141 is a clinical study titled "Trauma Intervention for Affect Regulation, AIDS, and Substances". The Purpose of this study is to see if it is possible to deliver an intervention that targets trauma, substance use, and engagement in HIV care with HIV-positive women.

What is the current status of trial NCT02923141?

This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2017-01. Estimated completion is 2018-07.

What conditions does trial NCT02923141 study?

This clinical trial studies the following conditions: Post Traumatic Stress Disorder, Human Immunodeficiency Virus, Substance Related Disorder.

What interventions are being tested in trial NCT02923141?

The interventions under investigation include: Contingency Management (BEHAVIORAL), Neutral Writing (BEHAVIORAL), Expressive Writing (BEHAVIORAL).

Who is sponsoring clinical trial NCT02923141?

This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02923141 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Post Traumatic Stress Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02923141's enrollment target sits among peer trials

16 245th of 262 higher than 16 of 262 other Post Traumatic Stress Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Post Traumatic Stress Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02422641 · 16 participants · Phase 2

    Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis

  • NCT02851758 · 16 participants · NA

    Transplantation of Autologously Derived Mitochondria Following Ischemia

  • NCT03291028 · 16 participants

    Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma

  • NCT03425526 · 16 participants · Phase 1

    Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02923141, the US trial registry maintained by the National Library of Medicine. NCT02923141 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.